Venture capital firm the Autism Impact Fund has reached the first close of its second fund, which will prioritize investments in autism, behavioral health and mental health solutions.
Originally launched in 2021, the company now manages $150 million. Its first investment fund closed with $60 million in capital in 2024. Autism Impact Fund (AIF) currently has 17 companies in its portfolio with two successful exits.
Chris Male, co-founder and co-managing partner of AIF, said the scope of its next investments will prioritize innovative companies that show improved outcomes and reduce cost, particularly as increased behavioral health utilization has been cited for driving up costs across health care.
“As the costs rise and with everything going on in ABA, it’s our belief that those that are operating with transparency, focused on improving and measuring outcomes and cutting costs are really going to be the winners, and it raises the bar,” Male told Behavioral Health Business. “So investing with those who are best aligned with payers, aligned with policy — that is really where we want to focus. And that will filter out some of the weaker players or bad actors in the space.”
AIF is also looking at broadening its scope of investable opportunities across other complex mental health conditions like ADHD, dyslexia, depression and anxiety, he said.
“Autism isn’t one thing, right? It’s a variety of biological disorders,” Male said. “It’s such a wide spectrum that the opportunities are significantly larger, and we’re able to invest in opportunities where autism alone is a smaller portion of the business model, which increases the addressable market and de-risks the opportunities for us. So we just have further conviction with that.”
The company already invests in established providers in the sector, such as Cortica Autism Care, Imagine Pediatrics and Bluebird Kids Health, among others.
Last year, AIF invested in Unison Therapy Services, a multi-specialty youth and family behavioral health provider. Shortly after, AIF also landed $10 million in capital from the firm Fairfield-Maxwell Ltd. to fuel its second investment fund.
As it deploys capital from its second investment fund, Male said the current pipeline of opportunities AIF is eyeing is “robust” and that it will likely have more news to share soon as new deals are finalized.
The three biggest areas of growth Male and the team at AIF will be watching are technology and AI-enabled autism care solutions, broader behavioral and mental health solutions for co-occurring conditions and value-based care models.
“We don’t view AI as a standalone theme,” Male said. “We view it more as infrastructure to support connecting data, personalizing diagnosis, personalizing outcomes and really connecting those dots. There’s so much data in the space that’s wasted and unused. Being able to capture that with AI, with tech to improve outcomes and cut costs, will certainly be where we see a lot of the capital flowing.”
From his vantage point, Male said that while the market sectors AIF is focused on are currently attracting significant capital, traditional models are of less interest to investors right now, and that is likely to continue.
“Those that are innovating to provide better care and outcomes, in addition to lowering the total costs at scale, is really where you’re starting to see a lot of dollars flow — whether that’s value-based care models or in AI to run things more efficiently,” Male said. “That’s where we’re headed. And in traditional ABA, where all the money has flowed before, I think you’ll see the shift we already are seeing, of moving investments into the more innovative models.”